Profusa CEO Ben Hwang on Why Continuous Biochemical Monitoring Could Revolutionize Precision Medicine and Clinical Trials

  As healthcare shifts toward precision medicine and data-driven care, continuous biochemical monitoring is emerging as a transfo...

May 14, 2026 | Thursday | Expert Opinion
Gyre Therapeutics Achieves Key Regulatory Milestone as China Accepts NDA for F351 Liver Fibrosis Treatment

Gyre Therapeutics, Inc. (“Gyre”, “Gyre Therapeutics” or the “Company”) (Nasdaq: GYRE), an innovative, commercial-stag...

May 14, 2026 | Thursday | News
Dark Horse Consulting Group and KunTuo Forge Strategic Alliance to Accelerate Biotherapeutic Clinical Trials in China

Dark Horse Consulting Group, a leading strategic and operational consulting enterprise in the field of biological therapy (hereinafter referred to as " DHC...

May 13, 2026 | Wednesday | News
Roche Secures CE Mark for First Single-Assay Blood Test to Rule In and Rule Out Alzheimer’s Pathology

Roche has received CE Mark approval for Elecsys® pTau217, a blood-based diagnostic test designed to detect phosphorylated Tau (pTau) 217 protein, a k...

May 13, 2026 | Wednesday | News
ArriVent BioPharma Secures FDA IND Clearance for Dual-Target ADC ARR-002 in Ovarian and Endometrial Cancers

Superior efficacy and favorable tolerability in animal models support the potential of ARR-002 to overcome limitations of single-target approaches Pha...

May 08, 2026 | Friday | News
Silo Pharma Launches Ibogaine-Based TBI Therapeutics Initiative Amid Growing Federal Support for Psychedelic Medicine Innovation

New initiative from Silo Pharma designed to align with federal actions to accelerate mental health innovation using psychedelic medicines Silo Pharma ta...

May 08, 2026 | Friday | News
arcoris bio Launches immunoMUSE® Kits to Advance Custom Multiplex Biomarker Detection

arcoris bio, a Swiss life science research tools and in vitro diagnostics company, today announced the launch of its immunoMUSE® kits, based on its ...

May 07, 2026 | Thursday | News
Lunai Bioworks Expands CNS Platform with $20 Million IP Acquisition to Advance Alzheimer’s and Neurotherapeutic Programs

Transaction Adds Dual BBB Delivery Strategies, Supports Alzheimer's Programs, Combination Therapies, 505(b)(2) Pathways, and CNS Countermeasure Applicati...

May 06, 2026 | Wednesday | News
Advancing Precision Radiotherapeutics for Hard-to-Treat CNS Cancers

  Central nervous system (CNS) cancers remain among the most difficult diseases to treat in oncology, with limited therapeutic options, complex deliv...

May 04, 2026 | Monday | Interaction
Turning Clinical Complexity into Predictive Intelligence: How BullFrog AI Is Redefining Drug Development

As pharmaceutical companies continue to face high attrition rates, rising development costs and increasingly complex clinical datasets, the industry is sea...

May 04, 2026 | Monday | Interview
Cleaning Beyond Compliance: How Biopharma Manufacturers Can Unlock Capacity Through Smarter Contamination Control

  As biologics manufacturing operations become increasingly complex, biopharma companies are under growing pressure to improve efficiency, strengthen...

May 04, 2026 | Monday | Interaction
LTS LOHMANN Therapie-Systeme AG Expands CDMO Portfolio with U.S.-Based Ophthalmic Drug Delivery Services

LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company specializing in advanced drug delivery systems, announced the expans...

April 01, 2026 | Wednesday | News
TrialClinIQ Secures Pre-Seed Funding and Accelerator Backing to Advance Equitable Clinical Trial Access

TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, announced a $150K pre-seed investment fro...

April 30, 2026 | Thursday | News
Thermo Fisher Scientific Opens Flagship Bioprocess Design Center in Massachusetts to Accelerate Biologics Development

  Expansion of Plainville, Mass., facility offers bioprocessing expertise, advanced technologies and customized support Thermo Fisher Scientific Inc...

April 29, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close